Advertisement

Health

Health ministry questions reliability of vasculitis drug approval data

Katherine Langford
Editor-in-Chief · Thursday, October 22, 2026 at 3:40 AM · 1 min read
 Health ministry questions reliability of vasculitis drug approval data  — Japan Times, Austin Health news
Image: Japan Times

Tavneos was launched in Japan in 2022 after being approved by the ministry. Its package insert listed liver dysfunction as a serious side effect.

Up nextAustin ISD to end monthly health savings account contributions for employees in 2027Health · 1 min read
#wellness
You're offline — showing the last loaded page